2xnb
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:2xnb.png|left|200px]] | |
- | [[Image:2xnb. | + | |
<!-- | <!-- | ||
Line 10: | Line 9: | ||
{{STRUCTURE_2xnb| PDB=2xnb | SCENE= }} | {{STRUCTURE_2xnb| PDB=2xnb | SCENE= }} | ||
- | === | + | ===Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents=== |
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_21035734}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 21035734 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_21035734}} | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[2xnb]] is a 1 chain structure of [[Cell Division Protein Kinase 2]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XNB OCA]. | |
+ | |||
+ | ==See Also== | ||
+ | *[[Cell Division Protein Kinase 2]] | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:021035734</ref><references group="xtra"/> | ||
[[Category: Cyclin-dependent kinase]] | [[Category: Cyclin-dependent kinase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Line 42: | Line 53: | ||
[[Category: Cell cycle]] | [[Category: Cell cycle]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 10 06:45:31 2010'' |
Revision as of 06:27, 28 March 2012
Contents |
Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents
Template:ABSTRACT PUBMED 21035734
About this Structure
2xnb is a 1 chain structure of Cell Division Protein Kinase 2 with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Wang S, Griffiths G, Midgley CA, Barnett AL, Cooper M, Grabarek J, Ingram L, Jackson W, Kontopidis G, McClue SJ, McInnes C, McLachlan J, Meades C, Mezna M, Stuart I, Thomas MP, Zheleva DI, Lane DP, Jackson RC, Glover DM, Blake DG, Fischer PM. Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents. Chem Biol. 2010 Oct 29;17(10):1111-21. PMID:21035734 doi:10.1016/j.chembiol.2010.07.016
Categories: Cyclin-dependent kinase | Homo sapiens | Barnett, A L. | Blake, D G. | Cooper, M. | Fischer, P M. | Glover, D M. | Grabarek, J. | Griffiths, G. | Ingram, L. | Jackson, R C. | Jackson, W. | Kontopidis, G. | Lane, D P. | Mcclue, S J. | Mcinnes, C. | Mclachlan, J. | Meades, C. | Mezna, M. | Midgley, C A. | Stuart, I. | Thomas, M P. | Wang, S. | Zheleva, D I. | Cdk9 inhibitor | Cell cycle | Transferase